Shillong, Oct 16: Prof. (Dr.) Nalin Mehta, Director of NEIGRIHMS, dedicated the newly acquired State-of-the-Art Hyperthermic Intraperitoneal Chemotherapy (HIPEC) machine for patient care at the institute on 16th Oct 2024.
Dr Caleb Harris, Surgical Oncologist, highlighted the application of HIPEC explaining that it is used for instillation of heated chemotherapeutic agents into the abdominal cavity for effective treatment of peritoneal malignancies.
HIPEC has several advantages over standard chemotherapy. It is a single treatment done in the operating room, instead of multiple treatments over several weeks, and 90% of the drug stays within the abdominal cavity, thereby decreasing the toxic effects of chemotherapy on the rest of the body, while allowing for a more intense dose.
This offers hope for patients with dreaded cancers, for which the treatment otherwise was only palliative. Dr.Daniala C, Medical Superintendent said that NEIGRIHMS strives to offer the latest advances in cancer care to patients of North East India.
Director NEIGRIHMS Prof.(Dr.) Nalin Mehta added that NEIGRIHMS has made a steady rogress to make comprehensive and advanced cancer care available to the people of the region who otherwise travel to other parts of the country for cancer treatment.
HIPEC procedure was successfully performed in NEIGRIHMS earlier and now that the institute has procured this sophisticated equipmentso that numerous patients can benefit.
